Communicable disease threats report, 29 April - 5 May 2012, week 18
Risk assessment: Severe respiratory disease associated with a novel coronavirus, 26 September 2012
Following the identification of a novel coronavirus in two patients, both having been in Saudi Arabia albeit three months apart, ECDC has prepared a rapid risk assessment to consider the risk to the public in the EU.
Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012.
Palm, D., Pereyaslov, D., Vaz, J., Broberg, E., Zeller, H., Gross, D., Brown, C., Struelens, M., on behalf of the Joint ECDC-WHO Regional Office for Europe Novel Coronavirus Laboratory Survey participants, ECDC National Microbiology Focal Points, WHO European Region EuroFlu Network European Network for Diagnostics of Imported" Viral Diseases (ENIVD)."
Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.
Editorial commentary: Critical contribution of laboratories to outbreak response support for middle east respiratory syndrome coronavirus
Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the WHO European Region, June 2013
Pereyaslov, D., Rosin, P., Palm, D., Zeller, H., Gross, D., Brown, C.S., Struelens, M.J., Robo, A., Hatibi, I.H., Alis, J.C., Sargsyan, S., Gurbanov, S., Gribkova, N., van Ranst, M., Ieven, G., Patteet, S., Tomic, S., Korsun, N., Drazenovic, V., Pieridou-Bagkatzouni, D., Jirincova, H., Havlickova, M., Fomsgaard, A., Rae, K., Lappalainen, M., Ikonen, N., Lina, B., van der Werf, S., Manuguerra, J.-C., Machablishvili, A., Eickmann, M., Wolff, T., Dobler, G., Schmidt-Chanasit, J., Drosten, C., Papa, A., Mentis, A.F., Kis, Z., Love, A., Coughlan, S., Melboim, M., Capobianchi, M.R., Lini, M.P., Baldanti, F., Palu, G., Ghisetti, V., Donatelli, I., Nusupbayeva, G., Tokhtabakiyeva, Z., Kasymbekova, K., Storozenko, J., Erne, S., Griskevicius, A., Opp, M., Barbara, C., Vratnica, Z., Reusken, C., Dudman, S.G., Hungnes, O., Pancer, K., Guiomar, R., Eder V., Lupulescu, E., Yatsyshina, S., Pisareva, M., Buzitskaya, Z., Sergeev, A., Nedeljkovic, J., Staronova, E., Zupanc, T.A., Petrovec, M., Korva, M., Prosenc, K., Casas, I., Casas, I., Gaines, H., Cherpillod, P., Zakirova, N., Bosevska, G., Altas, B., Ciblak, M., Ciblak, M., Mironenko, A., Dykhanovska, T., Demchyshyna, I., Bermingham, A., Rakhimov, R.
RRA: Severe respiratory disease associated with MERS-CoV, 4th update; 17 May 2013
This fourth update of the rapid risk assessment of severe respiratory disease associated with a novel coronavirus (MERS-CoV) was produced in relation to 22 additional cases of laboratory-confirmed infections reported in the last two months.